Decisional regret, symptom burden, and quality of life following transoral robotic surgery for oropharyngeal cancer

Transoral robotic surgery (TORS) has equivalent oncologic control to radiotherapy with potential for improved quality of life (QOL) and lower patient-reported decisional regret. Cross-sectional study between 2016 and 2021 of TORS patients with early-stage oropharyngeal squamous cell carcinoma who co...

Full description

Saved in:
Bibliographic Details
Published in:Oral oncology 2023-11, Vol.146, p.106537-106537, Article 106537
Main Authors: Kwon, Jamie Jae Young, Liu, Alice Q, Milner, Thomas D, Prisman, Eitan
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c371t-b46d903c40afe03b3e1c4213fd991b4c49f6f52cee2c77f2745c998e4b9060b33
cites cdi_FETCH-LOGICAL-c371t-b46d903c40afe03b3e1c4213fd991b4c49f6f52cee2c77f2745c998e4b9060b33
container_end_page 106537
container_issue
container_start_page 106537
container_title Oral oncology
container_volume 146
creator Kwon, Jamie Jae Young
Liu, Alice Q
Milner, Thomas D
Prisman, Eitan
description Transoral robotic surgery (TORS) has equivalent oncologic control to radiotherapy with potential for improved quality of life (QOL) and lower patient-reported decisional regret. Cross-sectional study between 2016 and 2021 of TORS patients with early-stage oropharyngeal squamous cell carcinoma who completed the Decision Regret Scale (DRS), M. D. Anderson Dysphagia Inventory (MDADI), and University of Washington Quality of Life (UW-QOL). The median time from treatment to questionnaire completion was 1.8 years (IQR 1.4-3.3, range 1.0-5.6). Of 65 patients, 84.6% expressed no or mild decisional regret. Regret was not associated with clinical parameters or adjuvant treatment but was correlated with MDADI (τ  = -0.23, p 
doi_str_mv 10.1016/j.oraloncology.2023.106537
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2851142406</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2851142406</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-b46d903c40afe03b3e1c4213fd991b4c49f6f52cee2c77f2745c998e4b9060b33</originalsourceid><addsrcrecordid>eNpNkE1LxDAQhoMorl9_QYInD3ZNmqRtvInfIHjRc0jTSe2SJmvSIv33dtlVPM0w874zLw9CF5QsKaHF9WoZonbBm-BCOy1zkrN5UQhW7qEjWpUyI0Ky_blnRZVVrBQLdJzSihAiqCCHaDGPSik4O0LpHkyXuuC1wxHaCMMVTlO_HkKP6zE24K-w9g3-GrXrhgkHi11nAdvgXPjufIuHqH3aBMIx1GHoDE5jbCFOsybiEMP6U8fJtzArjPYG4ik6sNolONvVE_Tx-PB-95y9vj293N2-ZoaVdMhqXjSSMMOJtkBYzYAanlNmGylpzQ2XtrAiNwC5KUubl1wYKSvgtSQFqRk7QZfbu-sYvkZIg-q7ZMA57SGMSeWVoJTnnBSz9GYrNTGkFMGqdez6ObeiRG2gq5X6D11toKst9Nl8vvsz1j00f9ZfyuwHVriFJw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2851142406</pqid></control><display><type>article</type><title>Decisional regret, symptom burden, and quality of life following transoral robotic surgery for oropharyngeal cancer</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Kwon, Jamie Jae Young ; Liu, Alice Q ; Milner, Thomas D ; Prisman, Eitan</creator><creatorcontrib>Kwon, Jamie Jae Young ; Liu, Alice Q ; Milner, Thomas D ; Prisman, Eitan</creatorcontrib><description>Transoral robotic surgery (TORS) has equivalent oncologic control to radiotherapy with potential for improved quality of life (QOL) and lower patient-reported decisional regret. Cross-sectional study between 2016 and 2021 of TORS patients with early-stage oropharyngeal squamous cell carcinoma who completed the Decision Regret Scale (DRS), M. D. Anderson Dysphagia Inventory (MDADI), and University of Washington Quality of Life (UW-QOL). The median time from treatment to questionnaire completion was 1.8 years (IQR 1.4-3.3, range 1.0-5.6). Of 65 patients, 84.6% expressed no or mild decisional regret. Regret was not associated with clinical parameters or adjuvant treatment but was correlated with MDADI (τ  = -0.23, p &lt; 0.001) and UW-QOL (τ  = -0.27, p &lt; 0.001). Worse MDADI was associated with older age and worse UW-QOL was associated with multi-site operation and shorter time to survey. Overall, the TORS cohort expressed very limited decisional regret. DRS scores were unaffected by clinicodemographics or additional adjuvant therapies, but decision regret was correlated with worse QOL and worse swallowing.</description><identifier>ISSN: 1368-8375</identifier><identifier>EISSN: 1879-0593</identifier><identifier>DOI: 10.1016/j.oraloncology.2023.106537</identifier><identifier>PMID: 37579543</identifier><language>eng</language><publisher>England</publisher><ispartof>Oral oncology, 2023-11, Vol.146, p.106537-106537, Article 106537</ispartof><rights>Copyright © 2023 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-b46d903c40afe03b3e1c4213fd991b4c49f6f52cee2c77f2745c998e4b9060b33</citedby><cites>FETCH-LOGICAL-c371t-b46d903c40afe03b3e1c4213fd991b4c49f6f52cee2c77f2745c998e4b9060b33</cites><orcidid>0000-0001-7201-6181</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37579543$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kwon, Jamie Jae Young</creatorcontrib><creatorcontrib>Liu, Alice Q</creatorcontrib><creatorcontrib>Milner, Thomas D</creatorcontrib><creatorcontrib>Prisman, Eitan</creatorcontrib><title>Decisional regret, symptom burden, and quality of life following transoral robotic surgery for oropharyngeal cancer</title><title>Oral oncology</title><addtitle>Oral Oncol</addtitle><description>Transoral robotic surgery (TORS) has equivalent oncologic control to radiotherapy with potential for improved quality of life (QOL) and lower patient-reported decisional regret. Cross-sectional study between 2016 and 2021 of TORS patients with early-stage oropharyngeal squamous cell carcinoma who completed the Decision Regret Scale (DRS), M. D. Anderson Dysphagia Inventory (MDADI), and University of Washington Quality of Life (UW-QOL). The median time from treatment to questionnaire completion was 1.8 years (IQR 1.4-3.3, range 1.0-5.6). Of 65 patients, 84.6% expressed no or mild decisional regret. Regret was not associated with clinical parameters or adjuvant treatment but was correlated with MDADI (τ  = -0.23, p &lt; 0.001) and UW-QOL (τ  = -0.27, p &lt; 0.001). Worse MDADI was associated with older age and worse UW-QOL was associated with multi-site operation and shorter time to survey. Overall, the TORS cohort expressed very limited decisional regret. DRS scores were unaffected by clinicodemographics or additional adjuvant therapies, but decision regret was correlated with worse QOL and worse swallowing.</description><issn>1368-8375</issn><issn>1879-0593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpNkE1LxDAQhoMorl9_QYInD3ZNmqRtvInfIHjRc0jTSe2SJmvSIv33dtlVPM0w874zLw9CF5QsKaHF9WoZonbBm-BCOy1zkrN5UQhW7qEjWpUyI0Ky_blnRZVVrBQLdJzSihAiqCCHaDGPSik4O0LpHkyXuuC1wxHaCMMVTlO_HkKP6zE24K-w9g3-GrXrhgkHi11nAdvgXPjufIuHqH3aBMIx1GHoDE5jbCFOsybiEMP6U8fJtzArjPYG4ik6sNolONvVE_Tx-PB-95y9vj293N2-ZoaVdMhqXjSSMMOJtkBYzYAanlNmGylpzQ2XtrAiNwC5KUubl1wYKSvgtSQFqRk7QZfbu-sYvkZIg-q7ZMA57SGMSeWVoJTnnBSz9GYrNTGkFMGqdez6ObeiRG2gq5X6D11toKst9Nl8vvsz1j00f9ZfyuwHVriFJw</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Kwon, Jamie Jae Young</creator><creator>Liu, Alice Q</creator><creator>Milner, Thomas D</creator><creator>Prisman, Eitan</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7201-6181</orcidid></search><sort><creationdate>20231101</creationdate><title>Decisional regret, symptom burden, and quality of life following transoral robotic surgery for oropharyngeal cancer</title><author>Kwon, Jamie Jae Young ; Liu, Alice Q ; Milner, Thomas D ; Prisman, Eitan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-b46d903c40afe03b3e1c4213fd991b4c49f6f52cee2c77f2745c998e4b9060b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kwon, Jamie Jae Young</creatorcontrib><creatorcontrib>Liu, Alice Q</creatorcontrib><creatorcontrib>Milner, Thomas D</creatorcontrib><creatorcontrib>Prisman, Eitan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Oral oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kwon, Jamie Jae Young</au><au>Liu, Alice Q</au><au>Milner, Thomas D</au><au>Prisman, Eitan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decisional regret, symptom burden, and quality of life following transoral robotic surgery for oropharyngeal cancer</atitle><jtitle>Oral oncology</jtitle><addtitle>Oral Oncol</addtitle><date>2023-11-01</date><risdate>2023</risdate><volume>146</volume><spage>106537</spage><epage>106537</epage><pages>106537-106537</pages><artnum>106537</artnum><issn>1368-8375</issn><eissn>1879-0593</eissn><abstract>Transoral robotic surgery (TORS) has equivalent oncologic control to radiotherapy with potential for improved quality of life (QOL) and lower patient-reported decisional regret. Cross-sectional study between 2016 and 2021 of TORS patients with early-stage oropharyngeal squamous cell carcinoma who completed the Decision Regret Scale (DRS), M. D. Anderson Dysphagia Inventory (MDADI), and University of Washington Quality of Life (UW-QOL). The median time from treatment to questionnaire completion was 1.8 years (IQR 1.4-3.3, range 1.0-5.6). Of 65 patients, 84.6% expressed no or mild decisional regret. Regret was not associated with clinical parameters or adjuvant treatment but was correlated with MDADI (τ  = -0.23, p &lt; 0.001) and UW-QOL (τ  = -0.27, p &lt; 0.001). Worse MDADI was associated with older age and worse UW-QOL was associated with multi-site operation and shorter time to survey. Overall, the TORS cohort expressed very limited decisional regret. DRS scores were unaffected by clinicodemographics or additional adjuvant therapies, but decision regret was correlated with worse QOL and worse swallowing.</abstract><cop>England</cop><pmid>37579543</pmid><doi>10.1016/j.oraloncology.2023.106537</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-7201-6181</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1368-8375
ispartof Oral oncology, 2023-11, Vol.146, p.106537-106537, Article 106537
issn 1368-8375
1879-0593
language eng
recordid cdi_proquest_miscellaneous_2851142406
source ScienceDirect Freedom Collection 2022-2024
title Decisional regret, symptom burden, and quality of life following transoral robotic surgery for oropharyngeal cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T13%3A49%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decisional%20regret,%20symptom%20burden,%20and%20quality%20of%20life%20following%20transoral%20robotic%20surgery%20for%20oropharyngeal%20cancer&rft.jtitle=Oral%20oncology&rft.au=Kwon,%20Jamie%20Jae%20Young&rft.date=2023-11-01&rft.volume=146&rft.spage=106537&rft.epage=106537&rft.pages=106537-106537&rft.artnum=106537&rft.issn=1368-8375&rft.eissn=1879-0593&rft_id=info:doi/10.1016/j.oraloncology.2023.106537&rft_dat=%3Cproquest_cross%3E2851142406%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c371t-b46d903c40afe03b3e1c4213fd991b4c49f6f52cee2c77f2745c998e4b9060b33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2851142406&rft_id=info:pmid/37579543&rfr_iscdi=true